TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Price | 1.60p on 18-07-2025 | at 18:50:05
---|---|
Change | 0.05p 3.23% |
Buy | 1.70p |
Sell | 1.50p |
Buy / Sell CIZ Shares |
Last Trade: | Buy 33,905.00 at 1.67p |
Day's Volume: | 239,687 |
Last Close: | 1.60p |
Open: | 1.55p |
ISIN: | GB00BNG2VN02 |
Day's Range | 1.55p - 1.60p |
52wk Range: | 1.25p - 2.65p |
Market Capitalisation: | £6.34m |
VWAP: | 1.584315p |
Shares in Issue: | 396.39m |
Sector: Medicine and Biotech
Cizzle Biotech (CIZ) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 33,905 | 1.67p | Ordinary |
16:26:35 - 18-Jul-25 |
Buy* | 48,502 | 1.67p | Ordinary |
16:25:39 - 18-Jul-25 |
Sell* | 100,000 | 1.53p | Ordinary |
16:21:44 - 18-Jul-25 |
Sell* | 45,917 | 1.53p | Ordinary |
13:56:17 - 18-Jul-25 |
Buy* | 10,000 | 1.67p | Ordinary |
11:43:11 - 18-Jul-25 |
Buy* | 527 | 1.70p | Ordinary |
10:38:24 - 18-Jul-25 |
Buy* | 292 | 1.70p | Ordinary |
10:01:42 - 18-Jul-25 |
Buy* | 30 | 1.70p | Ordinary |
09:47:19 - 18-Jul-25 |
Buy* | 14 | 1.70p | Ordinary |
09:46:40 - 18-Jul-25 |
Sell* | 500 | 1.40p | Ordinary |
09:08:37 - 18-Jul-25 |
Cizzle Biotech (CIZ) Regulatory News |
||
Date | Source | Headline |
---|---|---|
30th Jun 2025 1:45 pm | RNS | Result of AGM |
6th Jun 2025 11:00 am | RNS | Notice of AGM |
28th May 2025 7:00 am | RNS | Holding(s) in Company |
20th May 2025 7:00 am | RNS | £150,000 Convertible Loan Note Issue |
30th Apr 2025 11:18 am | RNS | Final results for the year ended 31 December 2024 |
28th Apr 2025 7:00 am | RNS | Contract in Caribbean and Update on CIZ1B |
14th Apr 2025 10:00 am | RNS-R | Launch of New Website |
25th Mar 2025 7:00 am | RNS | Appointment of Non-Executive Director |
24th Mar 2025 7:00 am | RNS | Update on Launch of CIZ1B Biomarker Assay |
2nd Jan 2025 7:00 am | RNS | Appointment of Professor Dawn Coverley as CSO |